Characterization of prostate cancer cell progression in zebrafish xenograft model

Xu,Wei; Foster,Brittany A.; Richards,Mackenzie; Bondioli,Kenneth R.; Shah,Girish; Green,Christopher C.

doi:10.3892/ijo.2017.4189

Characterization of prostate cancer cell progression in zebrafish xenograft model

Authors:
- Wei Xu
- Brittany A. Foster
- Mackenzie Richards
- Kenneth R. Bondioli
- Girish Shah
- Christopher C. Green
View Affiliations

Affiliations: Louisiana State University Agricultural Center, Baton Rouge, LA, USA, School of Pharmacy, University of Louisiana, Monroe, LA 71201, USA
Published online on: November 6, 2017 https://doi.org/10.3892/ijo.2017.4189
Pages: 252-260

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Early diagnosis of prostate cancer (PCa) is critical for the application of efficient treatment to PCa patients. However, the majority of PCas remains indolent from several months to several years before malignancy. Current diagnosis methods have limitations in their reliability and are inefficient in time cost. Thus, an efficient in vivo PCa cell xenograft model is highly desired for diagnostic studies in PCas. In the present study we present a standardized procedure to create a PCa cell xenograft model using zebrafish (Danio rerio) as the host. PC3-CTR cells, a cell line from adenocarcinoma with stable expression of calcitonin receptor (CRT), were subcutaneously injected into zebrafish larvae at 48 h post fertilization. The nursing conditions for the larvae were optimized with stable survival rates of post hatch and post PC3-CTR cell injection. In this system, the progression of PC3-CTR cells in vivo was evaluated by migration and proliferation of the cells. Massive migrations of PC3 cells in vivo were observed at post injection day (PID)3. The injected PC3-CTR cells eventually invaded the whole larval zebrafish at PID5. Quantification of PC3-CTR cell proliferation was done using quantitative PCR (qPCR) analysis targeting the expression profiles of two PCa housekeeping genes, TATA-binding protein (TBP) and hypoxanthine phosphoribosyltransferase 1 (HPRT1) encoding genes. The excessive proliferation of PC3 cells in vivo was detected with both qPCR assays. Expression levels of one non‑coding gene, prostate cancer associated 3 gene (pca3), and two other genes encoding transient receptor potential ion channel Melastatin 8 (trpm8) and prostate-specific membrane antigen (psma), showed a significantly enhanced aggressiveness of PC3-CTR cells in vivo. The model established in the present study provides an improved in vivo model for the diagnosis of PCas efficiently. This PCa cell xenograft model can also serve as a tool for high throughput anti-PCa drug screening in therapeutic treatments.

View Figures

View References

1	American Cancer Society: What are the key statistics about prostate cancer? 2015
2	van Leeuwen PJ, Connolly D, Gavin A, Roobol MJ, Black A, Bangma CH and Schröder FH: Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit. Eur J Cancer. 46:377–383. 2010. View Article : Google Scholar
3	Rajasekhar VK, Studer L, Gerald W, Socci ND and Scher HI: Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling. Nat Commun. 2:1622011. View Article : Google Scholar
4	Collins AT, Berry PA, Hyde C, Stower MJ and Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
5	Chen Y, Zhao J, Luo Y, Wang Y, Wei N and Jiang Y: Isolation and identification of cancer stem-like cells from side population of human prostate cancer cells. J Huazhong Univ Sci Technolog Med Sci. 32:697–703. 2012. View Article : Google Scholar : PubMed/NCBI
6	Bokhorst LP, Bangma CH, van Leenders GJ, Lous JJ, Moss SM, Schröder FH and Roobol MJ: Prostate-specific antigen-based prostate cancer screening: reduction of prostate cancer mortality after correction for nonattendance and contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer. Eur Urol. 65:329–336. 2013. View Article : Google Scholar : PubMed/NCBI
7	Shah G: A human cancer cell specific gene product. USPTO; Shah Girish V: 2011
8	Park SI, Kim SJ, McCauley LK and Gallick GE: Pre-clinical mouse models of human prostate cancer and their utility in drug discovery. Curr Protoc Pharmacol Chapter 14. Unit 14.15. 2010. View Article : Google Scholar
9	Hafeez BB, Zhong W, Fischer JW, Mustafa A, Shi X, Meske L, Hong H, Cai W, Havighurst T, Kim K, et al: Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoqui-none, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model. Mol Oncol. 7:428–439. 2013. View Article : Google Scholar : PubMed/NCBI
10	Hansen AG, Arnold SA, Jiang M, Palmer TD, Ketova T, Merkel A, Pickup M, Samaras S, Shyr Y, Moses HL, et al: ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone. Cancer Res. 74:1404–1415. 2014. View Article : Google Scholar : PubMed/NCBI
11	Moshal KS, Ferri-Lagneau KF and Leung T: Zebrafish model: Worth considering in defining tumor angiogenesis. Trends Cardiovasc Med. 20:114–119. 2010. View Article : Google Scholar
12	Liu S and Leach SD: Zebrafish models for cancer. Annu Rev Pathol. 6:71–93. 2011. View Article : Google Scholar : PubMed/NCBI
13	Tat J, Liu M and Wen XY: Zebrafish cancer and metastasis models for in vivo drug discovery. Drug Discov Today Technol. 10:e83–e89. 2013. View Article : Google Scholar : PubMed/NCBI
14	Yen J, White RM and Stemple DL: Zebrafish models of cancer: Progress and future challenges. Curr Opin Genet Dev. 24:38–45. 2014. View Article : Google Scholar : PubMed/NCBI
15	Patton EE and Zon LI: Taking human cancer genes to the fish: A transgenic model of melanoma in zebrafish. Zebrafish. 1:363–368. 2005. View Article : Google Scholar
16	White RM, Sessa A, Burke C, Bowman T, LeBlanc J, Ceol C, Bourque C, Dovey M, Goessling W, Burns CE, et al: Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell. 2:183–189. 2008. View Article : Google Scholar : PubMed/NCBI
17	Bansal N, Davis S, Tereshchenko I, Budak-Alpdogan T, Zhong H, Stein MN, Kim IY, Dipaola RS, Bertino JR and Sabaawy HE: Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesion. Prostate. 74:187–200. 2014. View Article : Google Scholar :
18	Shah GV, Muralidharan A, Gokulgandhi M, Soan K and Thomas S: Cadherin switching and activation of beta-catenin signaling underlie proinvasive actions of calcitonin-calcitonin receptor axis in prostate cancer. J Biol Chem. 284:1018–1030. 2009. View Article : Google Scholar :
19	Westerfield M: The zebrafish book A guide for the laboratory use of zebrafish (Danio rerio). 5th edition. University of Oregon Press; Eugene, OR: 2007
20	Schmidt U, Fuessel S, Koch R, Baretton GB, Lohse A, Tomasetti S, Unversucht S, Froehner M, Wirth MP and Meye A: Quantitative multi-gene expression profiling of primary prostate cancer. Prostate. 66:1521–1534. 2006. View Article : Google Scholar : PubMed/NCBI
21	Valente V, Teixeira SA, Neder L, Okamoto OK, Oba-Shinjo SM, Marie SK, Scrideli CA, Paçó-Larson ML and Carlotti CG Jr: Selection of suitable housekeeping genes for expression analysis in glioblastoma using quantitative RT-PCR. BMC Mol Biol. 10:172009. View Article : Google Scholar : PubMed/NCBI
22	Ohl F, Jung M, Xu C, Stephan C, Rabien A, Burkhardt M, Nitsche A, Kristiansen G, Loening SA, Radonić A, et al: Gene expression studies in prostate cancer tissue: Which reference gene should be selected for normalization? J Mol Med (Berl). 83:1014–1024. 2005. View Article : Google Scholar
23	Altschul SF, Gish W, Miller W, Myers EW and Lipman DJ: Basic local alignment search tool. J Mol Biol. 215:403–410. 1990. View Article : Google Scholar : PubMed/NCBI
24	Ferreira LB, Palumbo A, de Mello KD, Sternberg C, Caetano MS, de Oliveira FL, Neves AF, Nasciutti LE, Goulart LR and Gimba ER: PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling. BMC Cancer. 12:5072012. View Article : Google Scholar : PubMed/NCBI
25	Bai VU, Murthy S, Chinnakannu K, Muhletaler F, Tejwani S, Barrack ER, Kim SH, Menon M and Veer Reddy GP: Androgen regulated TRPM8 expression: A potential mRNA marker for metastatic prostate cancer detection in body fluids. Int J Oncol. 36:443–450. 2010.PubMed/NCBI
26	Ghosh A, Wang X, Klein E and Heston WD: Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness. Cancer Res. 65:727–731. 2005.PubMed/NCBI
27	Teng Y, Xie X, Walker S, White DT, Mumm JS and Cowell JK: Evaluating human cancer cell metastasis in zebrafish. BMC Cancer. 13:4532013. View Article : Google Scholar : PubMed/NCBI
28	Taylor AM and Zon LI: Zebrafish tumor assays: The state of transplantation. Zebrafish. 6:339–346. 2009. View Article : Google Scholar
29	Spaink HP, Cui C, Wiweger MI, Jansen HJ, Veneman WJ, Marín-Juez R, de Sonneville J, Ordas A, Torraca V, van der Ent W, et al: Robotic injection of zebrafish embryos for high-throughput screening in disease models. Methods. 62:246–254. 2013. View Article : Google Scholar : PubMed/NCBI
30	Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF and Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol. 17:16–23. 1979.PubMed/NCBI
31	Abasolo I, Yang L, Haleem R, Xiao W, Pio R, Cuttitta F, Montuenga LM, Kozlowski JM, Calvo A and Wang Z: Overexpression of adrenomedullin gene markedly inhibits proliferation of PC3 prostate cancer cells in vitro and in vivo. Mol Cell Endocrinol. 199:179–187. 2003. View Article : Google Scholar : PubMed/NCBI
32	Schneider CA, Rasband WS and Eliceiri KW: NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
33	Allocca G, Kusumbe AP, Ramasamy SK and Wang N: Confocal/two-photon microscopy in studying colonisation of cancer cells in bone using xenograft mouse models. Bonekey Rep. 5:8512016. View Article : Google Scholar : PubMed/NCBI
34	Chittajallu DR, Florian S, Kohler RH, Iwamoto Y, Orth JD, Weissleder R, Danuser G and Mitchison TJ: In vivo cell-cycle profiling in xenograft tumors by quantitative intravital microscopy. Nat Methods. 12:577–585. 2015. View Article : Google Scholar : PubMed/NCBI
35	Bocci G, Buffa F, Canu B, Concu R, Fioravanti A, Orlandi P and Pisanu T: A new biometric tool for three-dimensional subcutaneous tumor scanning in mice. In Vivo. 28:75–80. 2014.PubMed/NCBI
36	Oldham M, Sakhalkar H, Oliver T, Wang YM, Kirpatrick J, Cao Y, Badea C, Johnson GA and Dewhirst M: Three-dimensional imaging of xenograft tumors using optical computed and emission tomography. Med Phys. 33:3193–3202. 2006. View Article : Google Scholar : PubMed/NCBI
37	Tsaur I, Renninger M, Hennenlotter J, Oppermann E, Munz M, Kuehs U, Stenzl A and Schilling D: Reliable housekeeping gene combination for quantitative PCR of lymph nodes in patients with prostate cancer. Anticancer Res. 33:5243–5248. 2013.PubMed/NCBI
38	Rho HW, Lee BC, Choi ES, Choi IJ, Lee YS and Goh SH: Identification of valid reference genes for gene expression studies of human stomach cancer by reverse transcription-qPCR. BMC Cancer. 10:2402010. View Article : Google Scholar : PubMed/NCBI
39	Alcoser SY, Kimmel DJ, Borgel SD, Carter JP, Dougherty KM and Hollingshead MG: Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts. BMC Biotechnol. 11:1242011. View Article : Google Scholar : PubMed/NCBI
40	Preston Campbell J, Mulcrone P, Masood SK, Karolak M, Merkel A, Hebron K, Zijlstra A, Sterling J and Elefteriou F: TRIzol and Alu qPCR-based quantification of metastatic seeding within the skeleton. Sci Rep. 5:126352015. View Article : Google Scholar : PubMed/NCBI
41	Bussemakers MJ, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, Schalken JA, Debruyne FM, Ru N and Isaacs WB: DD3: A new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res. 59:5975–5979. 1999.PubMed/NCBI
42	Merola R, Tomao L, Antenucci A, Sperduti I, Sentinelli S, Masi S, Mandoj C, Orlandi G, Papalia R, Guaglianone S, et al: PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: A National Cancer Institute experience. J Exp Clin Cancer Res. 34:152015. View Article : Google Scholar : PubMed/NCBI
43	Galasso F, Giannella R, Bruni P, Giulivo R, Barbini VR, Disanto V, Leonardi R, Pansadoro V and Sepe G: PCA3: A new tool to diagnose prostate cancer (PCa) and a guidance in biopsy decisions. Preliminary report of the UrOP study. Arch Ital Urol Androl. 82:5–9. 2010.PubMed/NCBI
44	Wang Y, Wang X, Yang Z, Zhu G, Chen D and Meng Z: Menthol inhibits the proliferation and motility of prostate cancer DU145 cells. Pathol Oncol Res. 18:903–910. 2012. View Article : Google Scholar : PubMed/NCBI
45	Zhu G, Wang X, Yang Z, Cao H, Meng Z, Wang Y and Chen D: Effects of TRPM8 on the proliferation and angiogenesis of prostate cancer PC-3 cells in vivo. Oncol Lett. 2:1213–1217. 2011.
46	Wertz IE and Dixit VM: Characterization of calcium release-activated apoptosis of LNCaP prostate cancer cells. J Biol Chem. 275:11470–11477. 2000. View Article : Google Scholar
47	Gkika D, Flourakis M, Lemonnier L and Prevarskaya N: PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression. Oncogene. 29:4611–4616. 2010. View Article : Google Scholar : PubMed/NCBI
48	Zhang L and Barritt GJ: TRPM8 in prostate cancer cells: A potential diagnostic and prognostic marker with a secretory function? Endocr Relat Cancer. 13:27–38. 2006. View Article : Google Scholar : PubMed/NCBI
49	Sweat SD, Pacelli A, Murphy GP and Bostwick DG: Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology. 52:637–640. 1998. View Article : Google Scholar : PubMed/NCBI
50	Yao V, Berkman CE, Choi JK, O'Keefe DS and Bacich DJ: Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid. Prostate. 70:305–316. 2010.
51	Macciò A, Madeddu C, Gramignano G, Mulas C, Tanca L, Cherchi MC, Floris C, Omoto I, Barracca A and Ganz T: The role of inflammation, iron, and nutritional status in cancer-related anemia: Results of a large, prospective, observational study. Haematologica. 100:124–132. 2015. View Article : Google Scholar :